Reviewing the therapeutic role of budesonide in Crohn's disease
Por:
Lopez-Sanroman, A, Clofent, J, Garcia-Planella, E, Menchen, L, Nos, P, Rodriguez-Lago, I, Domenech, E
Publicada:
1 ago 2018
Resumen:
Oral budesonide is a glucocorticoid of primarily local action. In the field of digestive diseases, it is used mainly in inflammatory bowel disease, but also in other indications. This review addresses the pharmacology, pharmacodynamics and therapeutic use of budesonide. Its approved indications are reviewed, as well as other clinical scenarios in which it could play a role, in order to facilitate its use and improve the accuracy of its prescription. (C) 2018 The Author(s). Published by Elsevier Espana, S.L.U.
Filiaciones:
Lopez-Sanroman, A:
Hosp Ramon & Cajal, Serv Gastroenterol & Hepatol, Madrid, Spain
Clofent, J:
Hosp Sagunto, Serv Aparato Digest, Valencia, Spain
Garcia-Planella, E:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Menchen, L:
Hosp Gregorio Maranon, Madrid, Spain
Nos, P:
Hosp Politecn La Fe, Valencia, Spain
Rodriguez-Lago, I:
Hosp Galdakao, Serv Aparato Digest, Bilbao, Spain
Domenech, E:
Hosp Badalona Germans Trias & Pujol, Serv Aparell Digestiu, Barcelona, Spain
CIBEREHD, Madrid, Spain
Hybrid Gold
|